Gabon has taken another step in regulating its biodiversity. The exploitation and sale of iboga, a plant native to Central Africa with psychoactive and therapeutic properties, now requires strict government permission. Libreville is tightening access to this emblematic resource, which for long was harvested without any rigorous framework, while its global economic value has steadily risen over the past decade.

A strategic resource brought back under state control

The Tabernanthe iboga, a shrub from Gabon’s equatorial forests, holds a unique place in the country’s heritage. It is the cornerstone of the bwiti initiation ritual and is also studied by international biomedical research for its potential in treating addiction to opiates and cocaine. This dual cultural and pharmacological significance has attracted foreign operators, sometimes leading to uncontrolled exploitation of wild populations.

In response, the Gabonese government now requires all activities involving iboga—whether harvesting, processing, selling, or exporting—to obtain prior administrative authorization. This measure follows the protections put in place since the plant was classified as national cultural heritage in 2000. Concretely, no commercial operation can proceed without approval from the competent authorities, under penalty of sanctions.

Biological sovereignty and the fight against biopiracy

The decision addresses a long-standing concern for Gabonese authorities and civil society: the capture of benefits from the plant by foreign actors, with no returns for local communities or the state. For years, several European and North American clinics have offered treatments based on ibogaine, the alkaloid extracted from the root, at high prices. Yet the raw material comes mostly from Gabon’s forests, where wild harvesting threatens the species’ sustainability.

By tightening the legal framework, Libreville enables itself to trace flows, set quotas, and eventually negotiate access and benefit-sharing contracts in line with the Nagoya Protocol, to which Gabon is a party. This approach mirrors that of other Congo Basin countries seeking to protect their genetic resources. The challenge remains to build enforcement capacity on the ground, in a vast, hard-to-reach forest zone where illegal trade in non-timber forest products is a documented reality.

Building a structured industry between tradition and industry

Beyond the enforcement dimension, the new framework opens the way to structuring a genuine national industry. Interested players—whether traditional healers, village cooperatives, or industrialists—must follow a clearly defined administrative process. The country faces a double challenge: preserving slow-regenerating natural stands while capturing the value of a plant in demand by global pharmaceutical research.

Several operational questions remain. What criteria will determine eligibility for authorizations? Which ministry will oversee application processing? What role will be given to communities holding traditional knowledge of bwiti? The credibility of the system will largely depend on the transparency of procedures and the administration’s ability to balance economic interests with conservation imperatives.

For investors and international partners, the message is clear: iboga is no longer an open-access resource. Gabon, which in recent years has multiplied initiatives to valorize its natural capital—from carbon credits to forest certification—adds a new piece to its ecological sovereignty strategy. The reform’s success will be judged by the human and technical resources that the Gabonese transition dedicates to its implementation. The new authorization regime is already in effect nationwide.